These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29436378)

  • 1. Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.
    Selvin E; Warren B; He X; Sacks DB; Saenger AK
    Clin Chem; 2018 May; 64(5):843-850. PubMed ID: 29436378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
    Juraschek SP; Steffes MW; Selvin E
    Clin Chem; 2012 Dec; 58(12):1648-55. PubMed ID: 23019309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
    Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
    Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
    Parrinello CM; Selvin E
    Curr Diab Rep; 2014; 14(11):548. PubMed ID: 25249070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population.
    Zhou Q; Shi DB; Lv LY
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27859632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
    Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
    J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritability analysis of nontraditional glycemic biomarkers in the Atherosclerosis Risk in Communities Study.
    Loomis SJ; Tin A; Coresh J; Boerwinkle E; Pankow JS; Köttgen A; Selvin E; Duggal P
    Genet Epidemiol; 2019 Oct; 43(7):776-785. PubMed ID: 31218750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
    George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
    BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
    Tommerdahl KL; Brinton JT; Vigers T; Nadeau KJ; Zeitler PS; Chan CL
    Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
    Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J
    Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
    Parrinello CM; Sharrett AR; Maruthur NM; Bergenstal RM; Grams ME; Coresh J; Selvin E
    Diabetes Care; 2016 Apr; 39(4):589-95. PubMed ID: 26681712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
    Rooney MR; Tang O; Pankow JS; Selvin E
    Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results From the Atherosclerosis Risk in Communities Study.
    Loomis SJ; Li M; Maruthur NM; Baldridge AS; North KE; Mei H; Morrison A; Carson AP; Pankow JS; Boerwinkle E; Scharpf R; Rasmussen-Torvik LJ; Coresh J; Duggal P; Köttgen A; Selvin E
    Diabetes; 2018 Aug; 67(8):1684-1696. PubMed ID: 29844224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
    Selvin E; Rawlings AM; Grams M; Klein R; Sharrett AR; Steffes M; Coresh J
    Lancet Diabetes Endocrinol; 2014 Apr; 2(4):279-288. PubMed ID: 24703046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative markers of hyperglycemia and risk of diabetes.
    Juraschek SP; Steffes MW; Miller ER; Selvin E
    Diabetes Care; 2012 Nov; 35(11):2265-70. PubMed ID: 22875225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus.
    Mendes N; Tavares Ribeiro R; Serrano F
    J Obstet Gynaecol; 2018 Aug; 38(6):762-769. PubMed ID: 29620435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.